Zobrazeno 1 - 10
of 23
pro vyhledávání: '"E.E. Shiller"'
Autor:
N.V. Shcherbakova, E.V. Kalinina, V.Yu. Petrov, I.N. Lavrentieva, G.N. Mustafina, M.V. Kosinova, E.V. Gapchenko, E.E. Shiller, A.V. Rogov, S.N. Duryagina, O.A. Markova, A.Yu. Borozinets, Pavel Svirin, K.S. Aslanyan, E.N. Lemazina, Vladimir Vdovin, Dmitry Kudlay, M.A. Timofeeva
Publikováno v:
Pediatria. Journal named after G.N. Speransky. 100:159-169
The main method of treatment for hemophilia A is replacement therapy with drugs of blood coagulation factors VIII (FVIII). The active use of biotechnological methods in the production of recombinant drugs contributes to the development and registrati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::450fda3121a7415f2edb2fe766dd29e0
https://doi.org/10.24110/0031-403x-2021-100-5-159-169
https://doi.org/10.24110/0031-403x-2021-100-5-159-169
Autor:
L.G. Basalaeva, V.M. Chernov, M.A. Timofeeva, E.V. Gapchenko, N.I. Zozulya, V. V. Shkryabunova, O.A. Krasheninnikova, I.N. Lavrentieva, T.V. Asekretova, A.Yu. Borozinets, O.A. Markova, Tatiana Andreeva, V.Yu. Petrov, K.G. Kopylov, Dmitry Kudlay, A.A. Rumyantsev, Saint Petersburg City Polyclinic No. , Saint Petersburg, Russia, E.E. Shiller, Igor Kurtov, Pavel Svirin, I.A. Lavrichenko, A.N. Mamaev, Vladimir Vdovin, Immunology named after Dmitry Rogachev, Moscow, Russia, Childhood Protection, Barnaul, Altai Krai, Russia, I.L. Davydkin, V.V. Lebedev
Publikováno v:
Pediatria. Journal named after G.N. Speransky. 100:236-245
Currently, the main method of treatment for hemophilia A is replacement therapy with drugs of blood coagulation factors VIII (FVIII). As a result of the development of new production technologies, recombinant FVIII are increasingly used for the treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::032327e128ad9fa191b6fec507848f1e
https://doi.org/10.24110/0031-403x-2021-100-2-236-245
https://doi.org/10.24110/0031-403x-2021-100-2-236-245
Autor:
Vladimir Vdovin, Tatiana Andreeva, V.V. Lebedev, I.L. Davydkin, A.Yu. Borozinets, Saint Petersburg City Polyclinic No. , Saint Petersburg, Russia, I.S. Tarasova, Pavel Svirin, E.E. Shiller, Dmitry Kudlay, Immunology named after Dmitry Rogachev, Moscow, Russia, Igor Kurtov, I.A. Lavrichenko, E.V. Gapchenko, V.Yu. Petrov, O.A. Markova, M.A. Timofeeva, T.V. Asekretova, O.A. Krasheninnikova
Publikováno v:
Pediatria. Journal named after G.N. Speransky. 99:190-198
Providing hemophilia patients with blood coagulation preparations is one of the priority tasks of the national health care system. In 2011, the first recombinant factor IX was created in Russia (rFIX, nonacog alpha, Innonafactor, GENERIUM JSC), that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::065fd2027922ff0f559c618c0eefe65a
https://doi.org/10.24110/0031-403x-2020-99-6-190-198
https://doi.org/10.24110/0031-403x-2020-99-6-190-198
Autor:
Dmitry Kudlay, F.G. Perina, Vladimir Vdovin, Alexandr Shuster, A.Yu. Borozinets, V.Yu. Petrov, Pavel Svirin, I.N. Lavrentyeva, E.E. Shiller
Publikováno v:
Pediatria. Journal named after G.N. Speransky. 99:168-175
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76a5fc40afb6c989cca22cf70e64f989
https://doi.org/10.24110/0031-403x-2020-99-3-168-175
https://doi.org/10.24110/0031-403x-2020-99-3-168-175
Autor:
F.G. Perina, Alexandr Shuster, Dmitry Kudlay, V.Yu. Petrov, E.E. Shiller, Pavel Svirin, Vladimir Vdovin, A.Yu. Borozinets
Publikováno v:
Pediatria. Journal named after G.N. Speransky. 98:103-110
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1c398eee0e0eca771e08095af2bdae7
https://doi.org/10.24110/0031-403x-2019-98-6-103-110
https://doi.org/10.24110/0031-403x-2019-98-6-103-110
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Haemophilia. 14:531-538
OCTANINE F is a high-purity blood clotting factor IX concentrate that has been shown to be effective and safe in adults with haemophilia B. At present, there are no prospective clinical study data on FIX replacement therapy in young children. The pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dc8c85ca402d7c91b3f1bfe0b6cc52a
https://doi.org/10.1111/j.1365-2516.2008.01678.x
https://doi.org/10.1111/j.1365-2516.2008.01678.x
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Victor Petrov, Eugene Nikitin, Pavel Svirin, Igor Koltunov, Ekaterina Klykova, E.E. Shiller, Dmitry Kudlay, Vladimir Vdovin, Artem Bullikh
Publikováno v:
Blood. 128:4980-4980
Background: Recent studies have shown that addition of bypassing agents to immuno-tolerance induction (ITI) protocol for patients with hemophilia A and inhibitor results in better control of bleeding episodes and improves quality of life. Few publica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e338fde9264e8afcb04b24ab76c3ee5d
https://doi.org/10.1182/blood.v128.22.4980.4980
https://doi.org/10.1182/blood.v128.22.4980.4980